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Sarcopenia, the age-related loss of muscle mass and 
force, is the major cause of frailty and fall-related injuries 
in the elderly [1]. Muscle repair and maintenance is 
facilitated by resident undifferentiated quiescent 
mononucleated cells, located beneath the basal lamina 
with properties of stem cells [2], these are also referred to 
as to satellite cells [3]. In response to muscle damage, 
satellite cells are activated to proliferate as myoblasts and 
migrate to the damaged region of the fiber, where they 
differentiate  and  fuse  to  form  myotubes  via  a  similar 
 
process to that of myogenesis [4]. This capacity is 
reduced in the elderly, where satellite cells are unable to 
efficiently execute the complete repair process, 
contributing to the loss of muscle mass [5,6].  
 
Although local and systemic changes of the stem cell 
niche modulate in part the stem cell fate, cell 
autonomous changes occur as organisms age [7], 
resulting in the inability of stem cells to proliferate, self-
renew or differentiate [8]. In skeletal muscle, previous 
studies have suggested that increased replicative history 
rather than chronological aging is the key aspect 

























Accumulation  of  oxidized  proteins  is  a  hallmark  of  cellular  and  organismal  aging.  Adult muscle  stem  cell  (or
satellite cell)  replication and differentiation  is compromised with age contributing  to sarcopenia. However,  the
molecular events related to satellite cell dysfunction during aging are not completely understood. In the present
study we have  addressed  the potential  impact of oxidatively modified proteins on  the  altered metabolism of
senescent human satellite cells. By using a modified proteomics analysis we have found that proteins involved in
protein quality control and glycolytic enzymes are the main targets of oxidation (carbonylation) and modification
with  advanced  glycation/lipid  peroxidation  end  products  during  the  replicative  senescence  of  satellite  cells.
Inactivation of the proteasome appeared to be a likely contributor to the accumulation of such damaged proteins.
Metabolic and functional analyses revealed an impaired glucose metabolism in senescent cells. A metabolic shift
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compromising satellite cell function [9].  Moreover, a 
hostile local environment in the aging organism may 
induce premature senescence or alter the stem cell niche 
leading to a decline in the satellite cell population, 
which in turn results in reduced growth potential of 
skeletal muscle in vivo [10]. The occurrence of 
premature senescence of satellite cells in the 
pathogenesis of muscular dystrophies is also an actual 
topic of research [11,12]. More importantly, senescent 
satellite cells show a decreased ability of differentiation 
and self-renewal [13]. Autophagy has recently been 
recognized as essential to maintain the mouse muscle 
stem cells in a quiescent state. Moreover,  in aged 
satellite cells autophagy is impaired and was found to 
cause premature entry into senescence by increased 
oxidative stress and loss of proteostasis [14]. However, 
the molecular mechanisms underlying the dysfunction 
of senescent myoblasts and how this could participate to 
muscle loss are not yet completely understood.  
  
Dysregulation of protein homeostasis and accumulation 
of oxidatively-damaged proteins by reactive oxygen 
species (ROS) and different processes related to the 
formation of advanced glycation/lipid peroxidation end 
products (AGEs and ALEs) are hallmarks of the aging 
process in different organs and tissues across different 
species [15,16]. In addition, cellular protein main-
tenance systems, such as the proteasome system, are 
often themselves affected during aging and upon 
oxidative stress, losing effectiveness over time [17]. 
Thus, it has been proposed that the accumulation of 
altered proteins during aging is due to both an increased 
production of ROS and other toxic compounds, as well 
as a decreased efficacy of the mechanisms responsible 
for their removal or repair [18,19].  
  
Among the many types of oxidative protein 
modifications described, carbonylation is one of the most 
prominent. Protein carbonylation is irreversible and is 
related to loss of function or gain of toxic function of the 
targeted proteins [20]. However, the question, whether 
protein carbonylation is causally involved in aging and 
age-related diseases, remains unanswered. In recent 
years, different studies have evidenced that the “Oxi-
proteome” (the build-up of carbonylated proteins) during 
aging and age-related diseases is composed only by a 
limited group of proteins [21], indicating that not all 
proteins have the same propensity for accumulation as 
oxidatively damaged proteins [22]. This sub-set of 
oxidation-prone proteins includes those involved in key 
cellular functions, such as protein quality control and 
cellular metabolism [22]. 
 
Although impairment of protein homeostasis and 
dysregulation of cellular metabolism have both been 
described to occur during cellular aging [23-25], up to 
now, these processes have been viewed as independent 
events. In this study, we have shown, by integrating 
modification proteomics and metabolic approaches, a 
functional connection between oxidative protein 
modifications and impairment of the related cellular 




Alteration of protein homeostasis during 
replicative senescence of human satellite cells 
 
Muscle derived satellite cells isolated from a 5-day-old 
infant were cultivated until they reached replicative 
senescence at about 48 cumulative population doublings 
(CPD). Muscle derived satellite cells, also referred as 








































vitro.  (A)  Immunocytochemistry  against  desmin  evidences
morphological  changes  in  senescent  human  myoblasts    (SEN)
when  compared  to  young  cells  (CPD  30).  Note  the  increased
diameter  and  irregular  shapes  of  the  formers,  as  previously
described [13]. (B) p16 protein levels during replicative senescence
in human myoblasts. (C) Densitometric analysis of the p16/emerin
ratio  showed a  significant  increase  (n=3; *P<0.001)  in p16  levels
during replicative senescence. P16 protein levels are expressed as
relative values and shown as mean ± S.D.  
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senescent at the end of their replicative life span when 
they ceased to respond to mitogenic stimuli and no 
population doublings were observed during a 4 week 
period. Senescent myoblasts exhibited typical 
morphological changes characteristic of senescent cells 
as they became flattened and enlarged when compared 
to young cells (Figure 1A). To further validate our 
model of cellular aging, we investigated the expression 
of the biomarker of senescence p16 (INK4a) protein 
(Figure 1B) and found it significantly increased during 
replicative senescence (Figure 1C). The accumulated 
p16 will bind the cyclin-dependent kinase 4 (Cdk4), 
thus inhibiting its activity and blocking the cell-cycle 










































Proteasome inhibition appears to be significantly 
associated with the onset of in vitro cellular senescence 
in multiple cell types such as BJ [27] and WI38 
fibroblasts [28]. However, data on senescent human 
myoblasts have not yet been reported. As depicted in 
Figure 2, a significant decrease in chymotrypsin-like 
(Figure 2A), trypsin-like (Figure 2B) and caspase-like 
(Figure 2C) proteasome peptidase activities was 
observed in human myoblasts undergoing replicative 
senescence (starting after 40 CPD). A decreased 
expression of the catalytic beta subunits in senescent WI 
38 human fibroblasts has also been reported [28], 
explaining the observed decreased activities. However, 
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catalytic subunits (ß1, ß2 and ß5) remained constant 
during their replicative span (Figure 2D and 2E). These 
results suggest the presence of internal inhibitors, such 
as highly oxidized and cross-linked proteins that could 
explain the decreased proteasome activity observed in 
senescent myoblasts. Previous studies have also shown 
an inactivation of the proteasome as a consequence of 
the oxidation of some of its subunits [29-31].  
  
Therefore, to gain further insights into the mechanisms 
that may be implicated in the impairment of proteasome 
activity and to further demonstrate the occurrence of 
deleterious protein modifications, the accumulation of 
proteins modified by carbonylation (Figure 2F), 









































peroxidation product HNE (Figure 2H), were 
monitored. Both carbonylated, glycated and HNE-
modified proteins were found to be increased during 
replicative senescence of human myoblasts. 
Interestingly, the threshold of accumulation starts after 
40 CPD, which is coincident with the kinetics of 
proteasome inhibition.  
 
Senescence-associated protein modifications target 
only a subset of the total proteome involved in key 
cellular pathways 
 
Although an increased level of damaged proteins has 
been shown to accumulate during aging and cellular 
















































the distribution of proteins  in  relation with  the modifications  studied  (see  also  Table  S1,  Table  S2  and  Table  S3).  (E) Modified
proteins were grouped into functional categories through the use of Ingenuity Pathways Analysis. The bars represent the biological
functions  identified, named  in the x‐axis. The dotted  line represents the threshold above which there are statistically significantly
more proteins in a biological function than expected by chance. The identified proteins associated with each pathway are indicated.
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in most cases the specific proteins targeted by these 
modifications have not yet been identified. The 
identification of these proteins may give insights into 
the mechanisms by which these damaged proteins could 
affect cellular functions. For this purpose, total protein 
extracts from young (30 CPD) and senescent myoblasts 
were resolved by two-dimensional electrophoresis (2D-
PAGE). For each sample, two gel series were prepared 
in parallel, one for Coomassie colloidal blue staining to 
visualize the total protein profile and equal loading 
control, and the second for immunodetection of 
carbonylated, glycated or HNE-modified proteins 
(Figure 3A, 3B and 3C). Interestingly, the pattern of the 
modified proteins was not superimposable with the 
pattern obtained for the total protein staining, 
suggesting that certain proteins represent preferential 
targets for these detrimental modifications. 
  
After analyses, during replicative senescence 22 protein 
spots were shown to be increasingly carbonylated (Figure 
3A), 24 were increasingly glycated (Figure 3B), and 8 
were increasingly modified by HNE (Figure 3C). Each 
spot was excised from the gel and analyzed by MALDI-
TOF/TOF-MS for protein identification. All spots were 
successfully identified (Tables S1, S2 and S3).  Proteins 
were identified as targets of one, two or the three 
modifications (Figure 3D). The identified proteins were 
then analyzed and grouped by metabolic pathways and 
cellular functions (Figure 3E). Major biological functions 
include carbohydrate metabolism, cellular morphology, 
migration and proliferation, as well as protein quality 
control, protein degradation and free radical scavenging. 
We identified 6 enzymes involved in glycolysis to be 
increasingly modified in the senescent myoblasts (Figure 
4A), these were aldolase (ALDOA), triosephosphate 
isomerase (TPIS), glyceraldehyde 3-phosphate dehydro-
genase (GAPDH), phosphoglycerate mutase (PGAM), 
enolase (ENOA) and pyruvate kinase (PKM1/M2). To 
further investigate whether these modifications result in a 
modification of the glycolytic pathway, the steady-state 
levels of related metabolites were measured and glucose 
oxidation flux analyses were performed.  
 
Impairment of glucose oxidation in senescent human 
myoblasts 
 
Glycolytic intermediates such as glucose-6-phosphate, 
fructose-6-phosphate, and the isobar containing fructose 
1,6-diphosphate, glucose 1,6-diphosphate, and myo-
inositol 1,4 or 1,3-diphosphate were all found to be 
decreased (Figure 4B), suggesting a decreased glucose 
metabolism via glycolysis in senescent myoblasts.  
Pyruvate produced through glycolysis is transported 
into mitochondria to generate acetyl-CoA. The major 
metabolic fate of acetyl-CoA is to enter the 
tricarboxylic (TCA) cycle to drive the production of 
reducing equivalents that in turn fuel the mitochondrial 
electron transport chain for ATP generation by 
oxidative phosphorylation. Senescent myoblasts had 
decreased levels of acetyl-CoA, succinate and malate 
(Figure 4B), suggesting an altered TCA cycle flux in 
aged myoblasts. Metabolic failure in senescent 
myoblasts is also supported by a decreased cellular 
reducing potential indicated by the increase in the 
NAD+/NADH ratio due to higher NAD+ levels whereas 
NADH remained unchanged (Figure 4B).  The 
oxidative modifications of glycolytic enzymes 
concomitant with the alteration of metabolites involved 
in this pathway suggested that myoblasts undergoing 
replicative senescence present dynamic changes in 
overall glucose metabolism. Nonetheless, the metabolite 
profiling analyses measure steady-state levels and are 
not conclusive in determining the actual flux of 
glycolytic metabolites. To directly address the 
hypothesis of impaired glucose metabolism during 
senescence, we measured [U-14C] glucose oxidation 
into CO2, which requires both glycolysis and TCA 
cycle. As depicted in Figure 4C, 14CO2 production from 
[U-14C] glucose was decreased by about 40% in 
senescent myoblasts when compared to their young 
counterparts. Thus, senescent myoblasts exhibited a 
substantial decrease in glucose oxidation likely due to 
impaired glycolysis and TCA cycle.  
  
Since TCA cycle flux depends on the oxidation of 
reduced equivalents (NADH, FADH2) by the 
mitochondrial respiratory chain, the oxygen 
consumption rate (OCR) of young and senescent cells 
was measured by a pharmacological profiling approach 
using the Seahorse instrument as previously described 
[32]. Previous studies have shown that the 
mitochondrial content increases in senescent cells as a 
function of cell size whereas mitochondrial density 
remained similar [33,34]. Due to the low number of 
cells required for the OCR experiments, it was more 
straightforward to determine cellular size rather than 
mitochondrial protein content, for which a much higher 
number of cells is needed. When the OCR were 
normalized to cellular size, the basal and maximal 
respiration rates were significantly higher in senescent 
myoblasts compared to young cells (CPD 30), whereas 
the spare respiratory capacity was unchanged (Figure 
4D). The non-ATP generating respiration (leak) was 
increased (P<0.01), thus maintaining similar respiratory 
control in young (1.70 ± 0.2) and senescent cells (1.59 ± 
0.1, P = ns). No evidence of uncoupling was observed. 
Taken together these results indicate that senescent 
myoblasts have a decreased capacity to oxidize glucose 
but their mitochondrial respiration capacity is not 
compromised, suggesting a direct impairment upstream 
in glycolysis and/or in the TCA cycle as supported by 
the targeted proteomics and the metabolic analyses.   



















































Increased mobilization of non-carbohydrate 
substrates for energy production in senescent human 
myoblasts 
 
Degradation of branched chain amino acids (BCAAs), 



















































CoA, propionyl-CoA, and succinyl-CoA, which can 
contribute to energy production via the TCA cycle [35]. 
Increased levels of leucine and valine in senescent myo-
blasts (Figure 5A), concomitant with the accumulation of 
their carnitine conjugates (Figure 5B), suggests an increa-
sed catabolism of BCAAs during replicative senescence.   
Figure 4. Central metabolism alterations in senescent satellite cells. (A) Modified enzymes identified in senescent cells and
related to the central metabolism are represented in boxes. (B) Altered metabolites of central metabolism profiling in young (30 CPD)
(MY)  and  senescent myoblast  (MS).  For  the  box  plots,  the  top  and  bottom  of  the  boxes  represent  the  75th  and  25th  percentile,
respectively.  The  solid  bar  across  the  box  represents  the  median  value,  while  the  +  is  the  mean.  Any  statistical  outliers  are
represented by a  circle.  The  Y axis  is  the median  scaled  value  (relative  level).  The  fold  change  and  the  corresponding p  value  in




cyanide m‐chlorophenylhydrazone  (CCCP;  1‐30  μM)  to  determine  the maximal  respiration  rate.  The  respiration  reserve  capacity
(spare) was calculated by subtracting the basal to the maximal respiration. The OCR values were normalized to cellular size.   








































Another specific metabolic feature of senescent 
myoblasts concerns lipid metabolism. Indeed, except for 
arachidonate (C20:4n6) whose level was increased, 
several free mono- and polyunsaturated fatty acids with 
a chain length higher than 18 carbons were found to be 
decreased, while free medium-chain fatty acids 
remained unchanged (Figure 6A). This may reflect a 
decreased synthesis of these specific fatty acids or an 
increased incorporation into specific cellular lipids. 
However, increased levels of several monoacyl 
glycerols and glycerol-3-phosphate (Figure 6B, left 
panel) as well as of glycerophosphorylcholine, phospho-
ethanolamine, choline and ethanolamine (Figure 6B, right 
panel) in senescent myoblasts suggest an increased 
turnover of storage lipids (triacyglycerols) and of 
membrane lipids (glycerophospholipids), pointing 








































This hypothesis was further reinforced by the 
observation that the level of several acyl-carnitines was 
markedly increased during replicative senescence 
(Figure 6C), suggesting an increased fatty acid β-
oxidation. Such changes in lipid metabolism may also 
reflect changes in membrane composition during 
replicative senescence, which could also impact on lipid 
signaling as shown by the increased level of 
arachidonate (Figure 6A), a precursor of various 
eicosanoids. Remarkably, we also noticed an enhanced 
sphingomyelin metabolism in senescent myoblasts as 
shown by the increased levels of palmitoyl and stearoyl 
sphingomyelin and shingosine, whereas the sphinganine 
level decreased (Figure 6D). More importantly, sphin-
gomyelin can release ceramide, a signaling molecule 
implicated in aging [36].  Previous studies have shown 





















































































































Figure 6. Senescent satellite cells exhibit altered  lipid metabolism.  (A) Free  fatty acids profiling  in young  (MY) and
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dermal fibroblasts and endothelial cells inducing 
premature senescence by its ability to inhibit DNA 
synthesis and mitogenesis [37,38]. In addition, ceramide 
inhibitors increased the expression of myogenic 
differentiation markers and cell fusion rate in 
myoblasts, whereas short-chain ceramides inhibited 
these responses [39]. Indeed, the changes in sphingo-
myelinase and ceramide appear to specifically 
distinguish senescence from quiescent growth arrest.  
Although we were not able to detect ceramide, 
increased levels of its degradation product sphingosine 
and a decrease in its precursor sphinganine suggests that 
ceramide levels are differentially regulated in senescent 




The occurrence of increased molecular damage due to 
oxidation is well documented during aging and is 
believed to have a causative role in cellular aging [22]. 
Pioneer studies have  shown an increase in carbonylated 
proteins as well as proteins modified with HNE and 
AGEs in senescent WI-38 human embryonic fibroblasts 
[40].  It should be noted that the restricted sub-set of 
modified proteins in senescent myoblasts is different to 
those identified in senescent fibroblasts, even though 
similar proteomic approaches were used.  Whereas an 
important number of mitochondrial proteins were found 
to be increasingly modified in senescent fibroblasts 
[40], this was not the case for myoblasts, were most of 
the modified proteins are cytosolic. Our findings do not 
contradict the molecular damage theory of aging since 
increased oxidatively damaged proteins were still found 
in senescent cells. However, these data do challenge the 
preconception that the increased molecular damage is 
mainly caused by mitochondrial dysfunction.  
  
Differentially expressed proteins have been identified 
during replicative senescence of fibroblasts from 
different organisms [41,42]. However, due to a much 
smaller data set and fewer proteins identified, they were 
primarily focused on the differential expression levels 
of single proteins. Our study is the first large scale 
application of functional proteomics to replicative 
senescence of human myoblasts. Along with the 
comprehensive modification proteomics and metabolic 
data, coupled with functional analyses it provides a 
systems-level view to improve our understanding of 
cellular senescence. We have previously suggested that 
oxidative damage to key metabolic enzymes could be an 
important factor contributing to senescence and aging 
[21]. This study gives credit to our hypothesis and 
brings mechanistic insights as to how metabolic 
dysregulation during cellular aging may result, at least 
in part, from the oxidative damage of a restricted set of 
proteins. Indeed, the oxidative modification of enzymes 
involved in the glycolytic pathway is concomitant with 
a decreased cellular reducing potential, as demonstrated 
by the increased NAD+/NADH ratio, and decreased 
glucose oxidation. In addition, we have demonstrated 
that the functionality of the mitochondrial respiratory 
chain is not affected in human myoblasts during 
replicative senescence, indicating that the metabolic 
shift  which we observed is most likely due to an 
impairment in glycolysis and/or TCA cycle. Oxidative 
modifications of enzymes involved in glycolysis and the 
TCA cycle have also been suggested to be an important 
pathophysiological factor in age-related diseases, such 
as neurodegenerative diseases [43]. Other studies have 
shown that the inhibition of glycolytic enzymes, such as 
GAPDH and PGAM by siRNA can induce premature 
senescence [44]. In contrast, the proliferative capacity 
of murine embryonic stem cells closely correlates with 
high activity of different glycolytic enzymes, elevated 
glycolytic flux, and low mitochondrial oxygen 
consumption [45]. 
  
Previous studies in primary culture of human myoblasts 
have shown that a single treatment with exogenous 
hydrogen peroxide resulted in the loss of viability, a 
shorter population-doubling competence, and a 
significantly decreased proliferative capacity, 
suggesting an oxidative stress-induced premature 
senescence effect [5]. The proteome changes of adult 
human muscle stem cells in response to oxidative stress 
have been characterized [46]. Data mining of the 
identified carbonylated proteins suggested that 
carbohydrate metabolism is also affected by oxidative 
stress and that the impairment of these pathways may be 
implicated in the oxidative stress-induced cellular 
dysfunction. Our findings suggest an overall link 
between the bioenergetic status of myoblasts and their 
proliferation capacity. The metabolic changes we have 
identified during senescence have been shown to play a 
role in aging at the organismal level [47,48]. Senescent 
myoblasts exhibited a metabolic shift, with a pronounc-
ed down regulation in glycolysis coupled with an 
increased oxidation of long chain fatty acids and 
branched chain amino acids.  In addition, changes in 
lipid metabolism in senescent myoblasts may reflect 
membrane remodeling and changes in lipid-derived 
signaling molecules.  
  
In summary, we have described the occurrence of 
increased and targeted protein oxidative damage 
together with impaired cellular metabolism during 
replicative senescence of adult human muscle stem 
cells. By combining modification proteomics and 
metabolic analyses, in addition to functional studies, we 
have identified cellular pathways that are implicated in 
such processes. This study establishes a new link 
between oxidative protein modifications and the altered 
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cellular metabolism associated with the senescent 
phenotype. Future studies should provide a 
comprehensive view of benefits to be gained from 
increased protection against oxidative modification of 





Primary culture of human muscle satellite cells 
 
Satellite cells were isolated as previously described in 
accordance with the French legislation on ethical rules 
[49]. Using the explants method, upon autopsy, neonatal 
satellite cells were isolated from the quadriceps muscle 
of a 5-day-old female infant that died due to a 
developmental heart defect without showing signs of 
neuromuscular disorder. Cells were expanded in growth 
medium (DMEM 65%(v/v), 199 media 15% (v/v) and 
fetal bovine serum 20% (v/v)). Cultures were performed 
in a humidified atmosphere with 5% CO2 at 37ºC until 
sub-confluence. Magnetic-activated cell sorting 
(MACS) was used to purify myogenic cells using Mini 
MACS (Miltenyi Biotec, Ber-gisch Gladbach, 
Germany) using anti-neural cell adhesion molecule 
(NCAM) antibodies, according to manufacturer 
instructions. Sub-confluent cultures were obtained by 
seeding 4x105cells/225 cm2 culture flasks until they 
entered senescence. For each passage, cumulative 
population doublings (CPD) was calculated as: log 
(N/n)/ln 2, where N is the number of cells counted and n 
is the number of cells initially plated. In all 
experiments, myogenicity was greater than 95% as 
assessed by desmin immunostaining after 24h of 
differentiation by serum reduction to 2% (v/v). 
 
Proteasome peptidase activities 
   
Cell pellets derived from three independent experiments 
of cells at CPD: 30, 40, 46 and senescent were 
homogenized in an extraction buffer containing 50 mM 
Tris-HCl (pH 7) and 1 mM dithiothreitol. After 
clearance by centrifugation, protein concentration was 
determined by the Bradford method (Bio-Rad protein 
assay). Peptidase activities were assayed using the 
fluorescent peptide substrates: succinyl-Leu-Leu-Val-
Tyr-aminomethylcoumarin (LLVY-AMC) for the 
chymotrypsin-like activity, Ac-Arg-Leu-Arg-amino-
methylcoumarin (RLR-AMC) for the trypsin-like 
activity and N-benzyloxycarbonyl-Leu-Leu-Glu-ß-
naphthylamide (LLE-NA) for the peptidyl-glutamyl 
peptide hydrolyzing or caspase-like activity, as 
previously described [46].  Proteasome peptidase 
activities were determined as the difference between 
total activity and the remaining activity of the crude 
lysates in the presence of the proteasome inhibitor 
MG132 (20 µM). All measurements were performed in 
three different batches of cells, and results were 
expressed as mean ± standard deviation (SD). Data were 
analyzed two-way ANOVA followed by Bonferroni's 
post hoc test. * P<0.01. 
 
Protein extraction for proteomics analyses 
 
Cellular pellets derived from three independent 
experiments were homogenized using a lysis buffer (10 
mM tris-HCl (pH 7.4), 8 M urea, 2 M thiourea, 4% 
(w/v) CHAPS) and clarified by centrifugation. Proteins 
in the supernatant were precipitated using the 2-D 
Clean-Up kit (GE Healthcare). Protein precipitates were 
then resuspended in lysis buffer and protein quantifica-
tion was performed as described above.  
 
Immunodetection of carbonylated, HNE- and AGE-
modified proteins after 1D or 2D gel electrophoresis 
 
Immunoblot experiments for carbonyl detection were 
performed using the OxyBlotTM kit, according to the 
manufacturer instructions. Detection of HNE-modified 
proteins was achieved after overnight incubation at 4oC 
with polyclonal antibodies raised against HNE-modified 
KLH (ab46544, Abcam). For AGE-modified proteins, 
membranes were incubated with polyclonal antibodies 
raised against AGE-modified RNAse [50]. After 
washing, secondary antibodies IRDye were used, and 
membranes were scanned and quantified by the 
ODYSSEY infrared imaging system (LI-COR, Les Ulis, 
France). Two-dimensional polyacrylamide gel electro-
phoresis (2D PAGE) separation of proteins was 
performed as described previously [46]. For each 
sample, two gels were performed in parallel, one for 
colloidal blue staining of total proteins and other for 
electro-blotting onto nitrocellulose membranes. 
Membranes were then incubated for 2h in the blocking 
solution and immunodetection was performed as 
described above. Membranes were revealed using 
Amersham ECL Plus Western Blotting Detection 
System. Films were digitized with UMAX UTA-100 
scanner (GE Healthcare, Saclay, France) and 
densitometry analyses were performed using NIH 
ImageJ or Image Master 2D Platinum 7 software (GE 
Healthcare). 
 
Proteomics data acquisition and analysis 
 
 Spot detection and quantification was carried out using 
the Image Master 2D Platinum 7 software (GE 
Healthcare).  For each spot identified by Coomassie 
colloidal blue as well as from the corresponding 
immunodetection (carbonylated, AGE- and HNE-
modified proteins), a percentage volume was obtained in 
pixels (%Vol). The %Vol corresponds to a normalized 
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value of the spot volume by considering the total 
volume of all the spots present in the gels or on films. 
%Vol of carbonylated spots from young (CPD 30) and 
senescent cells were normalized with %Vol of the 
corresponding Coomassie-stained spot to obtain a 
normalized %Vol (N%Vol). The N%Vol of senescent 
cells was divided by the N%Vol of young cells to obtain 
the Relative Modification Index ratio (RMI ratio). Spots 
with an RMI ratio ≥1.3 were considered as increasingly 
modified in the senescent cells. All measurements were 
repeated a minimum of three times and results are 
expressed as mean ± standard deviation (S.D.). Data 
were tested for normality and statistical significance for 
the comparison of two groups using student's t-test: 
*P < 0.01. 
 
In-gel digestion, mass spectrometry protein 
identification and databases searches 
 
Spots of interest were manually excised from gels and 
proteins were digested with trypsin as described 
previously [40]. Peptide mass spectra were acquired in 
positive reflector mode on a 4800 Plus MALDI 
TOF/TOF™ Analyzer (Applied Biosystems, Foster 
City, CA, USA) using 20 kV of acceleration voltage. 
MS and MS/MS peak lists were combined into search 
files and used to search SwissProt database using the 
Mascot search engine (Matrix Science Ltd, London, 
UK). Mascot protein scores greater than 56 are 




Metabolites profiling analysis was performed by 
Metabolon, Inc. as previously described [51]. Cellular 
pellets (106 cells) from six different batches from young 
(CPD30) and senescent myoblasts were accessioned 
into the Metabolon LIMS system.  
 
Ultrahigh performance liquid chromatography/Mass 
Spectroscopy (UPLC/MS/MS) 
 The LC/MS portion of the platform was based on a 
Waters ACQUITY ultra-performance liquid chroma-
tography (UPLC) and a Thermo-Finnigan linear trap 
quadrupole (LTQ) mass spectrometer.  Sample extracts 
were dried and then reconstituted in acidic or basic LC-
compatible solvents, each of which contained 8 or more 
injection standards at fixed concentrations to ensure 
injection and chromatographic consistency.   
 
Gas chromatography/Mass Spectroscopy (GC/MS) 
The samples destined for GC/MS analysis were re-dried 
under vacuum desiccation for a minimum of 24h prior to 
being derivatized under dried nitrogen using 
bistrimethylsilyl-triflouroacetamide (BSTFA).  Samples 
were analyzed on a Thermo-Finnigan Trace DSQ fast-
scanning single-quadrupole mass spectrometer using 
electron impact ionization.   
 
Data extraction and compound identification 
Raw data was extracted, peak-identified and QC 
processed using Metabolon’s hardware and software 
[52]. Welch’s two-sample t-test was used to identify 
biochemicals that differed significantly between 
experimental groups.  
 
Measurement of glucose flux and oxygen 
consumption rates 
 
During the last 24 h of culture, the growth medium from 
young and senescent myoblasts was replaced by a 
medium containing 5 mM [U-14C]D-glucose (133 
µCi/nmol) and insulin (10 nM). After 24h, the medium 
was then collected to determine 14CO2, whereas cells 
were washed three times with ice-cold PBS and scraped 
for protein quantification. Oxygen consumption rate 
(OCR) was determined using Seahorse XF-96 
extracellular Flux analyzer (Seahorse Bioscience, 
Billerica, MA, USA) as previously described [32]. 
Briefly, young (CPD 30) and senescent cells were 
seeded in the 96-well XF-96 cell in sixteen replicates at 
20.000 cells/well in growth medium. Thirty minutes 
prior to the run, cells were equilibrated with new culture 
medium in a 37 °C CO2 incubator for pH and tem-
perature stabilization. Three mitochondrial inhibitors: 
oligomycin (1µM), carbonyl cyanide m-chloro-
phenylhydrazone (CCCP; 1-30 μM) and KCN (1mM) 
were sequentially injected (protocol, 12 min of 
equilibration, followed by measurements of 3 min, 
separated by mixing for 3 min).  After all the measure-
ments were completed, cells were dissociated and cell 
number was measured using a BD accuri cytometer (BD, 
Le Pont –de – Claix, France) while cell size was assessed 
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